Moderna, Generation Bio ink pact to develop non-viral genetic medicines Ruchika Sharma26 March 2023 11:00 AM ISTGeneration Bio will receive a USD 40 million upfront cash payment and a USD 36 million equity investment issued at a premium over recent share prices.
Moderna loses bid to shift liability in COVID vaccine patent case Ruchika Sharma12 March 2023 1:15 PM ISTDespite the backing of the U.S. government, Moderna Inc on Friday failed to persuade a federal judge it should not have to face a patent lawsuit...
Moderna-Merck gets USFDA Breakthrough Therapy Designation for personalized mRNA cancer vaccine in combination with KEYTRUDA to treat high risk melanoma Ruchika Sharma23 Feb 2023 2:45 PM ISTCambridge: Moderna, Inc. and Merck have announced that mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, in combination with...
Moderna gets Health Canada authorization for Omicron-targeting bivalent COVID booster vaccine for 6 to 17 years old Ruchika Sharma19 Feb 2023 1:00 PM ISTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that Health Canada has...
Moderna CEO to testify in senate on proposed COVID vaccine price hike Ruchika Sharma16 Feb 2023 1:30 PM ISTThe drugmaker, however, had said earlier today insured people could avail the vaccine at no cost at their doctor's office or local pharmacies, once...
Moderna gets USFDA Breakthrough Therapy Designation for RSV vaccine Ruchika Sharma1 Feb 2023 4:00 PM ISTmRNA-1345 is an investigational RSV vaccine that consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein.
Moderna, CytomX Therapeutics collaborate for mRNA-based conditionally activated therapeutics Ruchika Sharma8 Jan 2023 10:00 AM ISTCambridge: Moderna, Inc. and CytomX Therapeutics, Inc. have announced a collaboration and licensing agreement to create investigational mRNA-based...
Moderna to buy OriCiro Genomics for USD 85 million Ruchika Sharma5 Jan 2023 11:18 AM ISTCambridge: Moderna, Inc. and OriCiro Genomics K.K. have announced they have entered into a definitive agreement through which Moderna will...
Moderna fires back at Pfizer counterclaims in COVID vaccine patent lawsuit Ruchika Sharma24 Dec 2022 12:30 PM ISTModerna asked for an undisclosed amount of money damages from Pfizer COVID-19 vaccines sold since March.
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents Ruchika Sharma6 Dec 2022 1:30 PM ISTPfizer and BioNTech said in their Monday filing that they developed their vaccine independently, calling Moderna's lawsuit "revisionist history" and...
COVID trials improved diversity recruiting, says Moderna Top Scientist Ruchika Sharma3 Dec 2022 4:00 PM ISTNew York: Moderna Inc's top scientist has said that the vaccine maker has learned how to better recruit from diverse populations for its clinical...
Moderna gets Health Canada authorization for second Omicron -targeting Bivalent booster Ruchika Sharma6 Nov 2022 4:30 PM ISTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced Health Canada has...
